MENU
IDNA
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

iShares Genomics Immnlgy & Hlthcr ETF (IDNA) Ownership - Who owns iShares Genomics Immnlgy & Hlthcr ETF?

The investment seeks to track the investment results of the NYSE® FactSet® Global Genomics and Immuno Biopharma IndexTM... Show more

Category: #Health

Profile

Category
Health
Address
iShares Trust400 Howard StreetSan Francisco
Phone
1-800-474-2737
Web
www.ishares.com

Details

Group
Domestic Stock Funds
Category
Health
Net Assets
108141960.00
Fund Existence
almost 6 years
Turnover
51.00
Capitalization
N/A
Yield
1.09
Total Expense Ratio
0.47
Investment Style
N/A
Risk (Beta)
1.14

Fundamentals

IDNA
Net Assets
108M
Yield
1.09
Fund Existence
almost 6 years
Total Expense Ratio
0.47
Turnover
51.00
Investment Style
N/A
Capitalization
N/A
Risk (Beta)
1.14
Manager Tenure
N/A
Administrative Fee
N/A
Annual Report Gross Expense Ratio
0.47
Assets in Top Ten Holdings
58.8M
Average Credit Quality
N/A
Average Effective Duration
N/A
Average Effective Maturity
N/A
Fund of Funds
No
Fund Share Class Net Assets
108M
Fund Type
ETF
Index Fund
Yes
Management Fee
0.47
Modified Duration
N/A
No Load Fund
Yes
Number of Long Holdings
75.00
Number of Net Holdings
80.00
Number of Short Holdings
5.00
Prospectus Acquired Expense Ratio
N/A
Weighting Top Ten Holdings
49.99%
Gain YTD
-12.019
View a ticker or compare two or three
IDNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
iShares Trust400 Howard StreetSan Francisco
Phone
1-800-474-2737
Web
www.ishares.com